Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Stromal Vascular Fraction treatment increases hair density and thickness, making it a safe and effective treatment for Androgenetic Alopecia.

A 3-year-old girl with skin mast cell buildup and congenital baldness improved with treatment, suggesting a rare link between these conditions.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

A woman with alopecia totalis regrew dark hair in bands after using a corticosteroid ointment.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Baricitinib is effective and safe for treating severe alopecia areata.

PRP more effective than minoxidil 5% for treating alopecia areata.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

All types of Platelet-Rich Plasma (PRP) can treat hair loss, but homologous PRP works best due to its higher platelet count and growth factors from multiple donors.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

The study concluded that hair loss in Indian women is not significantly linked to anemia or thyroid problems, but checking thyroid function could help those with ongoing hair loss.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

BTA safely and effectively treats hair loss, and works better with FNS.

Misdiagnosis of LPP in AGA patients can cause hair transplant issues.

CK15 is not a reliable marker for stem cells in damaged hair follicles from patients with CCCA.